Qingdao Huapushi Technology Co., Ltd.

Qingdao Huapushi Technology is a digital health and pharmaceutical technology company that serves as the digital innovation arm of Qingdao Huanghai Pharmaceutical Co., Ltd. The company specializes in chronic disease management and pharmaceutical e-commerce, primarily focusing on the gout therapeutic area through its proprietary digital platform, 'Maidouyun' (麦豆云). The company integrates pharmaceutical retail with digital health services, providing patients with specialized care, medication management, and expert consultations. It is the primary entity managing the digital brand presence for 'Huapushi' (华普仕), which is the leading domestic brand of Febuxostat tablets produced by its parent company. Its operations bridge the gap between traditional pharmaceutical manufacturing and modern digital patient management systems.